Fund Holdings — Avidity Partners Management LP

Total Portfolio Value:
$624.44M
Total Bought:
$121.38M
Total Sold:
$40.46M
Net Transaction:
+$80.92M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Dianthus Therapeutics, Inc.(DNTH)2,104,1842,104,1840$176.58M$205.12M32.85%+$28.53M
CG Oncology, Inc.(CGON)1,288,9481,398,948+110,000$87.24M$99.40M15.92%+$12.16M
Oruka Therapeutics, Inc.(ORKA)760,424760,4240$37.30M$72.37M11.59%+$35.07M
JADE BIOSCIENCES INC1,400,7081,700,708+300,000$19.68M$37.79M6.05%+$18.11M
ENLIVEN THERAPEUTICS INC400,000550,000+150,000$15.68M$27.91M4.47%+$12.23M
PERSPECTIVE THERAPEUTICS INC6,049,9996,299,999+250,000$25.23M$21.48M3.44%-$3.75M
Aktis Oncology, Inc.(AKTS)468,566484,200+15,634$8.38M$15.61M2.50%+$7.22M
Palvella Therapeutics, Inc.(PVLA)70,00070,0000$8.73M$10.70M1.71%+$1.97M
MOBIA MED INC0798,282+798,282$0$10.70M1.71%+$10.70M
Repligen Corporation(RGEN)77,80077,8000$9.17M$10.62M1.70%+$1.45M
IMMUNIC INC0669,941+669,941$0$10.30M1.65%+$10.30M
SENSEONICS HLDGS INC01,600,000+1,600,000$0$9.09M1.46%+$9.09M
KARYOPHARM THERAPEUTICS INC463,741924,487+460,746$2.58M$9.03M1.45%+$6.45M
Teva Pharmaceutical Industries Limited(TEVA)450,100200,000-250,100$13.56M$6.78M1.09%-$6.78M
DexCom, Inc.(DXCM)90,000100,000+10,000$5.65M$6.74M1.08%+$1.08M
Tempus AI, Inc.(TEM)25,000105,000+80,000$1.13M$6.08M0.97%+$4.95M
Medtronic plc(MDT)100,00070,000-30,000$8.66M$5.48M0.88%-$3.19M
Vir Biotechnology, Inc.(VIR)950,000519,300-430,700$8.51M$5.29M0.85%-$3.22M
STRUCTURE THERAPEUTICS INC30,00098,000+68,000$1.45M$5.26M0.84%+$3.81M
Encompass Health Corporation(EHC)42,00042,0000$4.06M$4.25M0.68%+$182.7K
TENAX THERAPEUTICS INC215,934265,934+50,000$3.45M$3.87M0.62%+$416.6K
NUVECTIS PHARMA INC0200,000+200,000$0$3.68M0.59%+$3.68M
Insulet Corporation(PODD)024,000+24,000$0$3.65M0.59%+$3.65M
Boston Scientific Corporation(BSX)60,00080,000+20,000$3.77M$3.41M0.55%-$350.6K
SATELLOS BIOSCIENCE INC387,769387,7690$2.18M$3.01M0.48%+$831.8K
ALAMAR BIOSCIENCES INC0110,000+110,000$0$2.98M0.48%+$2.98M
CONTEXT THERAPEUTICS INC4,998,2674,998,2670$13.10M$2.77M0.44%-$10.33M
Gilead Sciences, Inc.(GILD)20,00020,0000$2.79M$2.53M0.40%-$260.6K
Charles River Laboratories International, Inc.(CRL)010,000+10,000$0$2.27M0.36%+$2.27M
PHATHOM PHARMACEUTICALS INC249,390200,000-49,390$2.77M$2.17M0.35%-$600.7K
AVALYN PHARMACEUTICALS INC060,000+60,000$0$1.98M0.32%+$1.98M
KAILERA THERAPEUTICS INC080,000+80,000$0$1.76M0.28%+$1.76M
Genmab A/S(GMAB)50,00050,0000$1.34M$1.37M0.22%+$32.0K
Intellia Therapeutics, Inc.(NTLA)75,00075,0000$961.5K$1.27M0.20%+$307.5K
Corvus Pharmaceuticals, Inc.(CRVS)115,00080,000-35,000$1.68M$1.20M0.19%-$487.3K
ODDITY TECH LTD
SHS CL A
70,00070,0000$936.6K$1.06M0.17%+$122.5K
SCYNEXIS INC0260,206+260,206$0$1.06M0.17%+$1.06M
EVOMMUNE INC075,000+75,000$0$996.8K0.16%+$996.8K
ABBOTT LABORATORIES010,000+10,000$0$907.4K0.15%+$907.4K
BridgeBio Pharma, Inc.(BBIO)010,000+10,000$0$744.8K0.12%+$744.8K
Peloton Interactive, Inc.(PTON)200,000100,000-100,000$858.0K$591.0K0.09%-$267.0K
Legend Biotech Corporation(LEGN)015,000+15,000$0$433.2K0.07%+$433.2K
BRIDGEBIO ONCOLOGY THERAPEUT43,85343,8530$392.5K$334.2K0.05%-$58.3K
Savara Inc.(SVRA)050,000+50,000$0$308.0K0.05%+$308.0K
Trevi Therapeutics, Inc.(TRVI)6,6606,6600$79.5K$124.2K0.02%+$44.8K
ABIVAX Société Anonyme(ABVX)10,0000-10,000$1.11M$0—-$1.11M
ACADIA PHARM12,9670-12,967$288.6K$0—-$288.6K
ANTERIS TECHNOLOGIES GLOBAL150,0000-150,000$832.5K$0—-$832.5K
ARBUTUS BIOPHARMA CORP125,0000-125,000$562.5K$0—-$562.5K
Centene Corporation(CNC)70,0000-70,000$2.29M$0—-$2.29M
Corcept Therapeutics Incorporated(CORT)30,0000-30,000$1.21M$0—-$1.21M
Hims & Hers Health, Inc.(HIMS)75,0000-75,000$1.56M$0—-$1.56M
ICON Public Limited Company(ICLR)16,0000-16,000$1.77M$0—-$1.77M
IMMUNIC INC6,699,4110-6,699,411$7.44M$0—-$7.44M
Kenvue Inc.(KVUE)100,0000-100,000$1.72M$0—-$1.72M
MoonLake Immunotherapeutics(MLTX)50,0000-50,000$932.0K$0—-$932.0K
Natera, Inc.(NTRA)9,0000-9,000$1.80M$0—-$1.80M
Revolution Medicines, Inc.(RVMD)15,0000-15,000$1.46M$0—-$1.46M
SCYNEXIS INC2,081,6600-2,081,660$1.91M$0—-$1.91M
UnitedHealth Group Incorporated(UNH)3,8000-3,800$1.03M$0—-$1.03M
Page 1 of 1
Avidity Partners Management LP — 13F Holdings — Q2 2026 | TickerTrail